Abstract
Non-tuberculous mycobacteria infect mostly immunocompromised people. NTM infections incidence and prevalence increase has led to a public health problem. Combretum species are used as food by humans and animals, and medicinal purposes. The aim of the study was to evaluate the antimycobacterial effects of plant extracts from selected Combretum species on Mycobacterium smegmatis and Mycobacterium aurum as well as their mode of action on the most susceptible organisms. Antimycobacterial activity of the plant extracts was screened. Mycobacterium smegmatis was more susceptible to the extracts. The potent Combretum extracts were investigated for their effects on Rhodamine 6G transport and biofilms in M. smegmatis. The amount of Rhodamine 6G accumulated in M. smegmatis in the presence of extracts were also investigated. The C. zeyheri acetone extracts were the most potent efflux pump inhibitors. Surface extracts from C. zeyheri were the most potent disrupters and inhibitors of biofilms. The ethylacetate extract of another species, C. apiculatum lacked the effect on biofilms and this may be due to the lack of penetration of the extract into the already established biofilm. The ultra-high performance liquid chromatography UPHLC-MS/MS analysis of acetone extracts from C. zeyheri indicated the presence of cirsimaritin, quinic acid, and ampelopsin glucoside and these could have contributed to the antimycobacterial activities of the extract. In conclusion, phytochemicals from C. zeyheri, C. platypetalum, C. apicultum species used in traditional medicine in Zimbabwe showed antimycobacterial and antibiofilm activity and may be used as sources of lead compounds targeting non-tuberculosis infections caused by M. smegmatis.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
Data availability
The datasets generated during the current study are available from the authors upon request.
References
Abebe G, Bonsa Z, Kebede W (2019) Treatment outcomes and associated factors in tuberculosis patients at Jimma University Medical Center: a 5-year retrospective study. Int J Mycobacteriol 8(1):35. https://doi.org/10.4103/ijmy.ijmy_177_18
Abu-Reidah IM, Arráez-Román D, Segura-Carretero A, Fernández-Gutiérrez A (2013) Extensive characterisation of bioactive phenolic constituents from globe artichoke (Cynara scolymus L.) by HPLC–DAD-ESI-QTOF-MS. Food Chem 141(3):2269–2277. https://doi.org/10.1016/j.foodchem.2013.04.066
Adegbola P, Aderibigbe I, Hammed W, Omotayo T (2017) Antioxidant and anti-inflammatory medicinal plants have potential role in the treatment of cardiovascular disease: a review. Am J Cardiovasc Dis 7(2):19
Adjemian J, Prevots DR, Gallagher J, Heap K, Gupta R, Griffith D (2014) Lack of adherence to evidence-based treatment guidelines for nontuberculous mycobacterial lung disease. Ann Am Thorac Soc 11(1):9–16. https://doi.org/10.1513/AnnalsATS.201304-085OC
Aeschlimann JR, Dresser LD, Kaatz GW, Rybak MJ (1999) Effects of NorA inhibitors on in vitro antibacterial activities and post antibiotic effects of levofloxacin, ciprofloxacin, and norfloxacin in genetically related strains of Staphylococcus aureus. Antimicrob Agents Chemother 43(2):335–340. https://doi.org/10.1128/AAC.43.2.335
Akinyemi KO, Oladapo O, Okwara CE, Ibe CC, Fasure KA (2005) Screening of crude extracts of six medicinal plants used in South–West Nigerian unorthodox medicine for anti-methicillin resistant Staphylococcus aureus activity. BMC Complement Altern Med 5(1):1–7. https://doi.org/10.1186/1472-6882-5-6
Akiyama K, Chikayama E, Yuasa H, Shimada Y, Tohge T (2008) PRIMe: a web site that assembles tools for metabolomics and transcriptomics. Silico Biol 8:339–345 (PMID: 19032166)
Asres K, Bucar F, Edelsbrunner S, Kartnig T, Höger G, Thiel W (2001) Investigations on antimycobacterial activity of some Ethiopian medicinal plants. Phytother Res 15(4):323–326. https://doi.org/10.1002/ptr.724
Bai J, Wu Y, Bu Q, Zhong K, Gao H (2022) Comparative study on antibacterial mechanism of shikimic acid and quinic acid against Staphylococcus aureus through transcriptomic and metabolomic approaches. LWT 153:112441. https://doi.org/10.1016/j.lwt.2021.112441
Beck JM, Rosen MJ, Peavy HH (2001) Pulmonary complications of HIV Infection: report of the fourth NHLBI workshop. Am J Respir Crit Care Med 164(11):2120–2126. https://doi.org/10.1164/ajrccm.164.11.2102047
Bekele B, Haile A (2020) Extraction, isolation and characterization of the stem bark of Combretum paniculatum occurring in South West Ethiopia. Int J Chem Sci 4(3):29–32
Benali T, Jaouadi I, Ghchime R, El Omari N, Harboul K, Hammani K, Rebezov M, Shariati MA, Mubarak MS, Simal-Gandara J, Zengin G (2022) The current state of knowledge in biological properties of cirsimaritin. Antioxidants 11(9):1842. https://doi.org/10.3390/antiox11091842
Berne C, Kysela DT, Brun YV (2010) A bacterial extracellular DNA inhibits settling of motile progeny cells within a biofilm. Mol Microbiol 77(4):815–829. https://doi.org/10.1111/j.1365-2958.2010.07267.x
Bhattacharya S, Sobel JD, White TC (2016) A combination fluorescence assay demonstrates increased efflux pump activity as a resistance mechanism in azole-resistant vaginal Candida albicans isolates. Antimicrob Agents Chemother 60(10):5858–5866. https://doi.org/10.1128/AAC.01252-16
Bouzaiene NN, Chaabane F, Sassi A, Chekir-Ghedira L, Ghedira K (2016) Effect of apigenin-7-glucoside, genkwanin and naringenin on tyrosinase activity and melanin synthesis in B16F10 melanoma cells. Life Sci 144:80–85. https://doi.org/10.1016/j.lfs.2015.11.030
Bryant JM, Grogono DM, Rodriguez-Rincon D, Everall I, Brown KP, Moreno P, Verma D, Hill E, Drijkoningen J, Gilligan P, Esther CR, Noone PG, Giddings O, Bell SC, Thomson R, Wainwright CE, Coulter C, Pandey S, Wood ME, Stockwell RE, Ramsay KA, Sherrard LJ, Kidd TJ, Jabbour N, Johnson GR, Knibbs LD, Morawska L, Sly PD, Jones A, Bilton D, Laurenson I, Ruddy M, Bourke S, Bowler IC, Chapman SJ, Clayton A, Cullen M, Daniels T, Dempsey O, Denton M, Desai M, Drew RJ, Edenborough F, Evans J, Folb J, Humphrey H, Isalska B, Jensen-Fangel S, Jönsson B, Jones AM, Katzenstein TL, Lillebaek T, MacGregor G, Mayell S, Millar M, Modha D, Nash EF, O’Brien C, O’Brien D, Ohri C, Pao CS, Peckham D, Perrin F, Perry A, Pressler T, Prtak L, Qvist T, Robb A, Rodgers H, Schaffer K, Shafi N, van Ingen J, Walshaw M, Watson D, West N, Whitehouse J, Haworth CS, Harris SR, Ordway D, Parkhill J, Floto RA (2016) Emergence and spread of a human-transmissible multidrug-resistant nontuberculous mycobacterium. Science 354(6313):751–757. https://doi.org/10.1126/science.aaf8156
Cerca N, Martins S, Pier GB, Oliveira R, Azeredo J (2005) The relationship between inhibition of bacterial adhesion to a solid surface by sub-MICs of antibiotics and subsequent development of a biofilm. Res Microbiol 156(5–6):650–655. https://doi.org/10.1016/j.resmic.2005.02.004
Chevalier FL, Cascioferro A, Majlessi L, Herrmann JL, Brosch R (2014) Mycobacterium tuberculosis evolutionary pathogenesis and its putative impact on drug development. Future Microbiol 9(8):969–985. https://doi.org/10.2217/fmb.14.70
Chiba A, Sugimoto S, Sato F, Hori S, Mizunoe Y (2015) A refined technique for extraction of extracellular matrices from bacterial biofilms and its applicability. Microb Biotechnol 8(3):392–403. https://doi.org/10.1111/1751-7915.12155
Chiramba O, Mukanganyama S (2016) Cytotoxic effects of Combretum platypetalum Welw. ex MA Lawson subsp. oatesii (Rolfe) Exell (Combretaceae) leaf extracts on Jurkat T-cells and reversal of effects by reduced glutathione. J Biol Active Prod Nat 6(3):250–265. https://doi.org/10.1080/22311866.2016.1232626
Costerton JW, Lewandowski Z, Caldwell DE, Korber DR, Lappin-Scott HM (1995) Microbial biofilms. Annu Rev Microbiol 49(1):711–745. https://doi.org/10.1146/annurev.mi.49.100195.003431
Das T, Kutty SK, Tavallaie R, Ibugo AI, Panchompoo J, Sehar S, Aldous L, Yeung AW, Thomas SR, Kumar N, Gooding JJ (2015) Phenazine virulence factor binding to extracellular DNA is important for Pseudomonas aeruginosa biofilm formation. Sci Rep 5(1):1–9. https://doi.org/10.1038/srep08398
Devaraj A, Buzzo JR, Mashburn-Warren L, Gloag ES, Novotny LA, Stoodley P, Bakaletz LO, Goodman SD (2019) The extracellular DNA lattice of bacterial biofilms is structurally related to Holliday junction recombination intermediates. PNAS 116(50):25068–25077. https://doi.org/10.1073/pnas.1909017116
Dye C (2009) Doomsday postponed? Preventing and reversing epidemics of drug-resistant tuberculosis. Nat Rev Microbiol 7(1):81–87. https://doi.org/10.1038/nrmicro2048
Egelund EF, Fennelly KP, Peloquin CA (2015) Medications and monitoring in nontuberculous mycobacteria infections. Clin Chest Med 36(1):55–66. https://doi.org/10.1016/j.ccm.2014.11.001
Eloff JN (1998) A sensitive and quick microplate method to determine the minimal inhibitory concentration of plant extracts for bacteria. Planta Med 64(08):711–713. https://doi.org/10.1055/s-2006-957563
Eloff JN (1999) The antibacterial activity of 27 Southern African members of the Combretaceae. S Afr J Sci 95(3):148–152
Flemming HC, Neu TR, Wozniak DJ (2007) The EPS matrix: the “house of biofilm cells.” J Bacteriol 189(22):7945–7947. https://doi.org/10.3390/microorganisms4040041
Flemming HC, Wingender J, Szewzyk U, Steinberg P, Rice SA, Kjelleberg S (2016) Biofilms: an emergent form of bacterial life. Nat Rev Microbiol 14(9):563–575. https://doi.org/10.1038/nrmicro.2016.94
Fyhrquist P, Mwasumbi L, Vuorela P, Vuorela H, Hiltunen R, Murphy C, Adlercreutz H (2006) Preliminary antiproliferative effects of some species of Terminalia, Combretum and Pteleopsis collected in Tanzania on some human cancer cell lines. Fitoterapia 77(5):358–366. https://doi.org/10.1016/j.fitote.2006.05.017
Green E, Samie A, Obi CL, Bessong PO, Ndip RN (2010) Inhibitory properties of selected South African medicinal plants against Mycobacterium tuberculosis. J Ethnopharmacol 130(1):151–157. https://doi.org/10.1016/j.jep.2010.04.033
Griffith DE, Aksamit T, Brown-Elliott BA, Catanzaro A, Daley C, Gordin F, Holland SM, Horsburgh R, Huitt G, Iademarco MF, Iseman M (2007) An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med 175(4):367–416. https://doi.org/10.1164/rccm.200604-571ST
Hall-Stoodley L, Lappin-Scott H (1998) Biofilm formation by the rapidly growing mycobacterial species Mycobacterium fortuitum. FEMS Microbiol Lett 168(1):77–84. https://doi.org/10.1111/j.1574-6968.1998.tb13258.x
Høiby N, Ciofu O, Bjarnsholt T (2010) Pseudomonas aeruginosa biofilms in cystic fibrosis. Future Microbiol 5(11):663–1674. https://doi.org/10.2217/fmb.10.125
Jamal M, Ahmad W, Andleeb S, Jalil F, Imran M, Nawaz MA, Hussain T, Ali M, Rafiq M, Kamil MA (2018) Bacterial biofilm and associated infections. J Chin Med Assoc 81(1):7–11. https://doi.org/10.1016/j.jcma.2017.07.012
Jimenez-Arellanes A, Meckes M, Ramirez R, Torres J, Luna-Herrera J (2003) Activity against multidrug-resistant Mycobacterium tuberculosis in Mexican plants used to treat respiratory diseases. Phytotherapy Res Int J Devoted Pharmacol Toxicol Eval Nat Prod Deriv 17(8):903–908. https://doi.org/10.1002/ptr.1377
Kaatz GW, Moudgal VV, Seo SM, Hansen JB, Kristiansen JE (2003) Phenylpiperidine selective serotonin reuptake inhibitors interfere with multidrug efflux pump activity in Staphylococcus aureus. Int J Antimicrob Agents 22(3):254–261. https://doi.org/10.1016/s0924-8579(03)00220-6
Kankya C, Muwonge A, Djønne B, Munyeme M, Opuda-Asibo J, Skjerve E, Oloya J, Edvardsen V, Johansen TB (2011) Isolation of non-tuberculous mycobacteria from pastoral ecosystems of Uganda: public health significance. BMC Public Health 11(1):1–9. https://doi.org/10.1186/1471-2458-11-320
Khan F, Oloketuyi SF, Kim YM (2019) Diversity of bacteria and bacterial products as antibiofilm and antiquorum sensing drugs against pathogenic bacteria. Curr Drug Targets 20(11):1156–1179. https://doi.org/10.2174/1389450120666190423161249
Kırmusaoğlu S (2019) The methods for detection of biofilm and screening antibiofilm activity of agents. Antimicrob Antibiot Resist Antibiofilm Strateg Act Methods. https://doi.org/10.5772/intechopen.84411
Kotze M, Eloff JN, Houghton PJ (2002) Extraction of antibacterial compounds from Combretum microphyllum (Combretaceae). S Afr J Bot 68(1):62–67. https://doi.org/10.1016/S0254-6299(15)30442-7
Luo X, Pires D, Aínsa JA, Gracia B, Duarte N, Mulhovo S, Anes E, Ferreira MJU (2013) Zanthoxylum capense constituents with antimycobacterial activity against Mycobacterium tuberculosis in vitro and ex vivo within human macrophages. J Ethnopharmacol 146(1):417–422. https://doi.org/10.1016/j.jep.2013.01.013
Mangoyi M, Mukanganyama S (2011) In vitro antifungal activities of selected medicinal plants from Zimbabwe against Candida albicans and Candida krusei. Afr J Plant Sci Biotechnol 5(1):8–14. http://www.globalsciencebooks.info/Online/GSBOnline/images/2011/AJPSB_5(1)/AJPSB_5(1)8-14o.pdf
Mangoyi R, Midiwo J, Mukanganyama S (2015) Isolation and characterization of an antifungal compound 5-hydroxy-7,4’-dimethoxyflavone from Combretum zeyheri. BMC Complement Altern Med 15:405. https://doi.org/10.1186/s12906-015-0934-7
Martini N, Eloff JN (1998) The preliminary isolation of several antibacterial compounds from Combretum erythrophyllum (Combretaceae). J Ethnopharmacol 62(3):255–263. https://doi.org/10.1016/S0378-8741(98)00067-1
Martini ND, Katerere DRP, Eloff JN (2004) Biological activity of five antibacterial flavonoids from Combretum erythrophyllum (Combretaceae). J Ethnopharmacol 93(2–3):207–212. https://doi.org/10.1016/j.jep.2004.02.030
Masoko P, Eloff JN (2007) Screening of twenty-four South African Combretum and six Terminalia species (Combretaceae) for antioxidant activities. Afr J Tradit Complement Altern Med 4(2):231–239. https://doi.org/10.4314/ajtcam.v4i2.31213
Masuko T, Minami A, Iwasaki N, Majima T, Nishimura SI, Lee YC (2005) Carbohydrate analysis by a phenol–sulfuric acid method in microplate format. Anal Biochem 339(1):69–72. https://doi.org/10.1016/j.ab.2004.12.001
McGaw LJ, Lall N, Meyer JJM, Eloff JN (2008) The potential of South African plants against mycobacterium infections. J Ethnopharmacol 119(3):482–500. https://doi.org/10.1016/j.jep.2008.08.022
Moco S, Bino RJ, Vorst O, Verhoeven HA, de Groot J, van Beek TA, Vervoort J, De Vos CR (2006) A liquid chromatography-mass spectrometry-based metabolome database for tomato. Plant Physiol 141(4):1205–1218. https://doi.org/10.1104/pp.106.078428
Moeng TE (2010) An investigation into the trade of medicinal plants by muthi shops and street vendors in the Limpopo province, South Africa (Doctoral dissertation).
Mombeshora M, Chi GF, Mukanganyama S (2021) Antibiofilm activity of extract and a compound isolated from Triumfetta welwitschii against Pseudomonas aeruginosa. Biochem Res Int. https://doi.org/10.1155/2021/9946183
Morales M, Ros Barcelo A, Pedreno MA (2000) Plant stilbenes: recent advances in their chemistry and biology. Adv Plant Physiol 3:39–70
Mortimer PGS, Piddock LJV (1991) A comparison of methods used for measuring the accumulation of quinolones by Enterobacteriaceae, Pseudomonas aeruginosa and Staphylococcus aureus. J Antimicrob Chemother 28(5):639–653. https://doi.org/10.1093/jac/28.5.639
Nguyen UT, Burrows LL (2014) DNase I and proteinase K impair Listeria monocytogenes biofilm formation and induce dispersal of pre-existing biofilms. Int J Food Microbiol 187:26–32. https://doi.org/10.1016/j.ijfoodmicro.2014.06.025
Nyambuya T, Mautsa R, Mukanganyama S (2017) Alkaloid extracts from Combretum zeyheri inhibit the growth of Mycobacterium smegmatis. BMC Complement Altern Med 17(1):1–11. https://doi.org/10.1186/s12906-017-1636-0
Ogodo AC, Tatah VS, Ebuara FU, Ogodo CF (2021) Therapeutic potentials of phytochemicals against Mycobacterium tuberculosis, the causative agent of tuberculosis. Negl Trop Dis Phytochem Drug Discov. https://doi.org/10.1002/9781119617143.ch22
Okoi C, Anderson ST, Antonio M, Mulwa SN, Gehre F, Adetifa IM (2017) Non-review and meta analyses. Sci Rep 7(1):1–12. https://doi.org/10.1038/s41598-017-12175-z
Okshevsky M, Meyer RL (2015) The role of extracellular DNA in the establishment, maintenance and perpetuation of bacterial biofilms. Crit Rev Microbiol 41(3):341–352. https://doi.org/10.3109/1040841X.2013.841639
Oloya B, Namukobe J, Ssengooba W, Afayoa M, Byamukama R (2022) Phytochemical screening, antimycobacterial activity and acute toxicity of crude extracts of selected medicinal plant species used locally in the treatment of tuberculosis in Uganda. Trop Med Health 50(1):1–13. https://doi.org/10.1186/s41182-022-00406-7
O’Toole GA (2011) Microtiter dish biofilm formation assay. J vis Exp 47:2437. https://doi.org/10.3791/2437
Panlilio H, Rice CV (2021) The role of extracellular DNA in the formation, architecture, stability, and treatment of bacterial biofilms. Biotechnol Bioeng 118(6):2129–2141. https://doi.org/10.1002/bit.27760
Pedrero S, Tabernero E, Arana-Arri E, Urra E, Larrea M, Zalacain R (2019) Changing epidemiology of nontuberculous mycobacterial lung disease over the last two decades in a region of the Basque country. ERJ Open Res. https://doi.org/10.1183/23120541.00110-2018
Pegel KH, Rogers CB (1985) The characterisation of mollic acid 3β-D-xyloside and its genuine aglycone mollic acid, two novel 1α-hydroxycycloartenoids from Combretum molle. J Chem Soc Perkin Trans 1:1711–1715. https://doi.org/10.1039/P19850001711
Piddock LJ (2006) Clinically relevant chromosomally encoded multidrug resistance efflux pumps in bacteria. Clin Microbiol Rev 19(2):382–402. https://doi.org/10.1128/CMR.19.2.382-402.2006
Piddock LJ, Garvey MI, Rahman MM, Gibbons S (2010) Natural and synthetic compounds such as trimethoprim behave as inhibitors of efflux in gram-negative bacteria. J Antimicrob Chemother 65(6):1215–1223. https://doi.org/10.1093/jac/dkq079
Pinto RM, Soares FA, Reis S, Nunes C, Van Dijck P (2020) Innovative strategies toward the disassembly of the EPS matrix in bacterial biofilms. Front Microbiol 11:952. https://doi.org/10.3389/fmicb.2020.00952
Poole K (2011) Pseudomonas aeruginosa: resistance to the max. Front Microbiol 2:65. https://doi.org/10.3389/fmicb.2011.00065
Prevots DR, Marras TK (2015) Epidemiology of human pulmonary infection with non-tuberculosis mycobacteria: a review. Clin Chest Med 36(1):13–34. https://doi.org/10.1016/j.ccm.2014.10.002
Rahmati S, Yang S, Davidson AL, Zechiedrich EL (2002) Control of the AcrAB multidrug efflux pump by quorum-sensing regulator SdiA. Mol Microbiol 43(3):677–685. https://doi.org/10.1186/1471-2180-6-53
Rajendran R, Mowat E, McCulloch E, Lappin DF, Jones B, Lang S, Majithiya JB, Warn P, Williams C, Ramage G (2011) Azole resistance of Aspergillus fumigatus biofilms is partly associated with efflux pump activity. Antimicrob Agents Chemother 55(5):2092–2097. https://doi.org/10.1128/AAC.01189-10
Rashid MI, Fareed MI, Rashid H, Aziz H, Ehsan N, Khalid S, Ghaffar I, Ali R, Gul A, Hakeem KR (2019) Flavonoids and their biological secrets. Plant Hum Health 2:579–605. https://doi.org/10.1007/978-3-030-03344-6_24
Rodgers CB, Verotta L (1996) Chemistry and biological properties of the African Combretaceae. In: Hostettman K, Chinyanganga F, Maillard M, Wolfender J-L, (eds) Chemistry, biological and pharmacological properties of African medicinal plants. University of Zimbabwe Publications, Harare
Roy R, Singh RK, Jash SK, Sarkar A, Gorai D (2014) Combretum quadrangulare (Combretaceae): phytochemical constituents and biological activity. Indo Am J Pharm Res 4(8):3416–3427
Runyoro DK, Srivastava SK, Darokar MP, Olipa ND, Joseph CC, Matee MI (2013) Anticandidiasis agents from a Tanzanian plant, Combretum zeyheri. Med Chem Res 22(3):1258–1262. https://doi.org/10.1007/s00044-012-0135-6
Samdumu FB. Ph.D. Thesis. Phytomedicine Programme, Department of Paraclinical Sciences, Faculty of Veterinary Sciences, University of Pretoria; Pretoria, South Africa (2007) Characterization of antimicrobial compounds from Combretum paniculatum, a plant with proven anti-HIV replication activity.
Sandasi M, Leonard CM, Van Vuuren SF, Viljoen AM (2011) Peppermint (Mentha piperita) inhibits microbial biofilms in vitro. S Afr J Bot 77(1):80–85. https://doi.org/10.1016/j.sajb.2010.05.011
Saxena S, Spaink HP, Forn-Cuní G (2021) Drug resistance in nontuberculous mycobacteria: mechanisms and models. Biology 10(2):96. https://doi.org/10.3390/biology10020096
Schulze-Robbecke R, Janning B, Fischeder R (1992) Occurrence of mycobacteria in biofilm samples. Tuber Lung Dis 73:141–144. https://doi.org/10.1016/0962-8479(92)90147-C
Selim SA, Adam ME, Hassan SM, Albalawi AR (2014) Chemical composition, antimicrobial and antibiofilm activity of the essential oil and methanol extract of the Mediterranean cypress (Cupressus sempervirens L.). BMC Complement Altern Med 14(1):1–8. https://doi.org/10.1186/1472-6882-14-179
Seukep AJ, Kuete V, Nahar L, Sarker SD, Guo M (2020) Plant-derived secondary metabolites as the main source of efflux pump inhibitors and methods for identification. J Pharm Anal 10(4):277–290. https://doi.org/10.1016/j.jpha.2019.11.002
Shadrina AA, Herdiyati Y, Wiani I, Satari MH, Kurnia D (2022) Prediction mechanism of nevadensin as antibacterial agent against S. sanguinis: in vitro and in silico studies. Comb Chem High Throughput Screen 25(9):1488–1497. https://doi.org/10.2174/1386207324666210707104440
Soto SM (2013) Role of efflux pumps in the antibiotic resistance of bacteria embedded in a biofilm. Virulence 4(3):223–229. https://doi.org/10.4161/viru.23724
Spies FS, Almeida da Silva PE, Ribeiro MO, Rossetti ML, Zaha A (2008) Identification of mutations related to streptomycin resistance in clinical isolates of Mycobacterium tuberculosis and possible involvement of efflux mechanism. Antimicrob Agents Chemother 52(8):2947–2949. https://doi.org/10.1128/AAC.01570-07
Stewart PS, Costerton JW (2001) Antibiotic resistance of bacteria in biofilms. Lancet 358(9276):135–138. https://doi.org/10.1016/s0140-6736(01)05321-1
Suksamrarn A, Poomsing P, Aroonrerk N, Punjanon T, Suksamrarn S, Kongkun S (2003) Antimycobacterial and antioxidant flavones from Limnophila geoffrayi. Arch Pharm Res 26(10):816–820. https://doi.org/10.1007/bf02980026
Suresh M, PK R, Panneerselvam A, Dhanasekaran D, Thajuddin N (2010) Anti-mycobacterial effect of leaf extract of Centella asiatica (Mackinlayaceae). Res J Pharm Technol 3(3):872–876
Tiwari PB, Chapagain PP, Seddek A, Annamalai T, Üren A, Tse-Dinh YC (2020) Covalent complex of DNA and bacterial topoisomerase: implications in antibacterial drug development. ChemMedChem 15(7):623–631. https://doi.org/10.1002/cmdc.201900721
van Tilburg Bernardes E, Lewenza S, Reckseidler-Zenteno S (2015) Current research approaches to target biofilm infections. Postdoc J J Postdr Res Postdr Affairs 3(6):36. https://doi.org/10.14304/surya.jpr.v3n6.5
Wang M, Firrman J, Liu L, Yam K (2019) A review on flavonoid apigenin: dietary intake, ADME, antimicrobial effects, and interactions with human gut microbiota. Biomed Res Int 2019:7010467. https://doi.org/10.1155/2019/7010467
Woo HJ, Kang HK, Nguyen TTH, Kim GE, Kim YM, Park JS, Kim D, Cha J, Moon YH, Nam SH, Xia YM (2012) Synthesis and characterization of ampelopsin glucosides using dextransucrase from Leuconostoc mesenteroides B-1299CB4: glucosylation enhancing physicochemical properties. Enzym Microb Technol 51(6–7):311–318. https://doi.org/10.1016/j.enzmictec.2012.07.014
Acknowledgements
Support from the Swedish International Development Agency (SIDA) through the International Science Programmes (ISP) (ISP IPICS: ZIM01, Uppsala University, Uppsala, Sweden), which supported the research under the Biomolecular Interaction Analysis group, is greatly appreciated. The authors are thankful to Mr. Christopher Chapano of the National Botanical and Herbarium Garden (Zimbabwe) for plant identification.
Funding
The authors declare that this study has no funding.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Ethical approval
This article does not contain any studies involving animals performed by any of the authors. This article does not contain any studies involving human participants performed by any of the authors.
Conflict of interest
Sharon Netsai Chikafa has no conflict of interest. Godloves Fru Chi has no conflict of interest. Stanley Mukanganyama has no conflict of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Chikafa, S.N., Fru, C.G. & Mukanganyama, S. Antimycobacterial, antibiofilm and efflux pump inhibitory activity of extracts from selected Combretum species used in traditional medicine in Zimbabwe. ADV TRADIT MED (ADTM) 24, 489–506 (2024). https://doi.org/10.1007/s13596-023-00711-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13596-023-00711-4